Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...
Patent
1997-01-08
1998-11-10
Stucker, Jeffrey
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Hormone or other secreted growth regulatory factor,...
4241841, A01N 6500
Patent
active
058339949
ABSTRACT:
The present invention includes the method of treating a viral infection, specifically one occurring as a result of infection by a human immunodeficiency virus (HIV-1). The method of treatment depends upon the ligand binding of the Ah receptor. Transformation and translocation of the receptor and DNA binding are not required. The study of compounds that interact with the Ah receptor, either as agonists, or antagonists, has resulted in the identification of compounds with useful therapeutic properties through perturbation of viral pathogenic signal transduction pathways. Antagonists of the Ah receptor are more likely candidates for treatment because the toxicity of such compounds is low. Identification of molecules affecting cellular targets, such as the Ah receptor, that inhibit viral pathologic signaling would be of great therapeutic potential as the activity of these molecules is not directed against the virus itself, therefore genetic viral mutation to escape such therapy would be far less likely to occur. The use of secondary compounds for use in combinational, synergistic, therapy is also enclosed. These second compounds are also known to have some effect on the treatment of cellular pathologic changes, together with those compounds found to be effective upon the regulation of the Ah receptor the compounds can more beneficially control virally induced cellular cytopathic changes.
REFERENCES:
El-Mekkawy et al. "Inhibitory Effects of Egyptian Folk Medicines on Human Immunodeficiency Virus (HIV) Reverse Transcriptase", Chemical and Pharmaceutical Bulletin, vol. 43, No. 4(Apr. 1995), pp. 641-648. RS1.C4 Abstract Only.
Mucsi et al. "Combined Effects of Flavonoids and Acyclovir Against Herpesviruses in Cell Cultures", Acta Microbiologica Hungarica, vol. 39, No. 2(1992), pp. 137-147. Abstract Only.
Serra et al. "Antiviral Activity of New Triterpenic Derivatives", Pharmacological Research, vol. 29, No. 4 (1994 May-Jun.), pp. 359-366. RS122.P45. Abstract Only.
Kerksiek et al. "Interaction of Cryptophycin 1 with Tubulin and Microtubules", FEBS Letters, vol. 377, No. 1 (1995 Dec. 11), pp. 59-61. QP501.F4.
Ono et al. "Differential Inhibitory Effects of Various Flavonoids on the Activities of Reverse Transcriptase and Cellular DNA and RNA Polymerases European Journal of Biochemistry, vol. 190, No. 3(Jul. 5, 1990), pp. 469-476. QP501.E89. Abstract Only.
Bauman, J.W. et al, (1995) Inhibitory Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on Rat Hepatocyte Proliferation Induced by 2/3 Partial Hepatectomy, Cell Proliferation 28: pp. 437-451.
Bjeldanes, L.F. et al, (1991) Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2,3,4,8-tetrachlorodibenzo-p-dioxin, Proc. Natl. Acad. Sci. USA 88:9543-9547.
Cohen, D.I. et al, (1992) Participation of Tyrosine Phosphorylation in the Cytopathic Effect of Human Immunodeficiency Virus-1, Science, 256: pp. 542-545.
Connor, R.I. et al, (1993) Increased Viral Burden and Cytopathicity Correlate Temporally with CD4+ T-Lymphocyte Decline and Cinical Progression in Human Immunodeficiency Virus Type 1-Infected Individuals, Journal of Virology, 67: pp. 1772-1777.
Corbeil, J., et al, (1996) HIV-Induced Apoptosis Requires the CD4 Receptor Cytoplasmic Tail and Is Accelerated by Interaction of CD4 with p561ck, Jour. Of Experimental Medicine, 183: pp. 39-48.
DeVito, M.J., et al, (1994) Dose-Response Relationships in Mice Following Subchronic Exposure to 2,3,7, 8-Tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, Estrogen Receptor, and Protein Tyrosine Phosphorylation, Toxicology and Applied Pharmacology, 124: pp. 82-90.
Fernandez-Salguero, P., et al, (1995) Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor, Science, 268: pp. 722-726.
Gasiewicz, T.A. et al, (1995), Alpha-Naphithoflavone acts as an antoagonist of 2,3,7,8-tetrachloro-dibenzo-p-dioxin by forming an inactive complex with the Ah receptor., Molecular Pharmacology 40: 607-612.
Heinkelein, M. Et al, (1995) Contact of Human Immunodeficiency Virus Type 1-Infected and Uninfected CD4+ T Lymphocytes is Highly Cytolytic for Both Cells, Journal of Virology 69: pp. 6925-6931.
Hivroz, c. Et al, (1993) Human Immunodeficiency Virus gp120 and Derived Peptides Activate Protein Tyrosine Kinase p561ck in Human CD4 T Lymphocytes, European Journal of Immunology 23: 600-607.
Jellinck, P.H., et al, (1993) Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation, Biochem. Pharmacol., 45: 1129-1136.
Kleman, M.I. et al, (1994), Regulation of human dioxin receptor function by indolocarbazoles, receptor ligands of dietary origin, J. Of Biol. Chem., 269: 5137-5144.
Kowalski, M. Et al, (1991), Attenuation of Human Immunodeficiency Virus Type 1 Cytopathic Effect by a Mutation Affecting the Transmembrane Envelope Glycoprotein, Journal of Virology 65: 281-291.
Landers, J.P et al, (1991), The Ah receptor and the mechanism of dioxin toxicity, Biochem J. 276: 273-278.
Lu, Y.F. et al, (1995) Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form on the nuclear Ah receptor in MCF-7 human breast cancer cells, Arch. Biochem Biophys., 316: 470-477.
Ma, X. Et al, (1992), Protein Tyrosine Phosphrylatio as a Indicator of 2,3, 7, 8-Tetrachloro-p-Dioxin exposure In Vivo and In Vitro, Biochemical and Biophysical Research Comm. 189):(1) pp. 59-65.
Ma, X. Et al, (1993), Acuate 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Exposure Results in Enhanced Tyrosylphosphorylation and Expression of Murine Hepatic Cyclin Dependent Kinases, Biochem and Biophysical Research Communications.
Merchant, M. Et al, (1995) In vitro inhibition of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl- 1,3,8- trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct, Biochem. Pharmacol. 50:663-668.
Poland, A. Et al, (1976), Sterospecific, high affinity binding of 2,3, 7, 8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase, J. Biol Chem. 251: 4936-4946.
Tani, Y. Et al, (1993), Normal T. Cell Receptor-Mediated Signaling in T Cell Lines Stably Expressing HIV-1 Envelope Glycoproteins, Journal of Immunology, 151: 7337-7348.
Wheelock, G.D. et al, (1996) Bioimmunoassay of Aryl Hydrocarbon (Ah) receptor Transformation in vitro by 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD), Toxicol. Methods 6:41-50.
Zacharewski, T. Et al, (1989), Induction of cytochrome P450-dependent monooxygenase activities in rat hepatoma H-4-HE cells in culture by 2,3,7,8-tetrachlorodibenzo-p- dioxin and related compounds; mechanistic studies using radiolabeled congeners, Arch. Biochem. Biophys. 272:344-355.
Bouton, A. H. Et al, 1991, Tryosine Phosphorylation of Three Cellular Proteins Correlates With Transformation of Rat 1 Cells by pp60.sup.src, Molecular Carcinogenesis 4: 145-152.
Farber, E., 1986, Chemical Carcinogenesis: The Liver as a Model.sup.1, Patho. Immumopathol. Res., 5:1-28.
Scambia, G., et al, (1993) Quercetin Induces Type-II Estrogen-Binding Sites in Estrogen-Receptor-Negative (MDA-MB231) and Estrogen-Receptor-Positive (MCF-7) Human Breast-Cancer Cell Lines.Int. J. Cancer: 54,462-466.
Dunnick, June K. & Hailey, James R. (1992) Toxicity and Carcinogenicity Studies of Quercetin, a Natural Component of Foods, Fundamental and Applied Toxicology 10, 423-431.
Astroff, B., et M., 6-Methyl-1, 3, 8-trichlorodibenzofuran as a 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin Antagonist: Inhibition of the Induction of Rat qtochrome P-450 Isozymes and Related Monooxygenase Activities, Mol. Pharm., 33:231-36 (1988).
Bannister, R., et al., 6-Methyl-1, 3, 8-'trichlorodibenzofuran as a 2, 3, 7 8Tetrachlorodibenzo-p-dioxin Antagonist in C57BL16 Mice, Toxicology 54:139-50 (1989).
Bartlett, R. and P. Nurse, Yeast as a model system for understanding the control of DNA replication in Eukaryotes, Bioessays 12: 457-463 (1990).
Choudhury, B.R., S.J. Haque, and M.K. Poddar
Babish John G.
Chigurupati Padmasree
Rininger Joseph
Wheelock Geoffrey D.
Paracelsian, Inc.
Stucker Jeffrey
LandOfFree
Use of the AH receptor and AH receptor ligands to treat or preve does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of the AH receptor and AH receptor ligands to treat or preve, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of the AH receptor and AH receptor ligands to treat or preve will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1514146